project id: TCGA-SKCM; case submitter id: TCGA-EE-A2GD; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 7.9; age at index: 58; days to birth: -21526; days to death: 10346; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1926; age at diagnosis: 21526; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T4; ajcc staging system edition: 2nd; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 9568.0; icd 10 code: C49.2; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of lower limb and hip; synchronous malignancy: Not Reported; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 1984; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 10016; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-EE-A2GD-06A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0; percent tumor nuclei: 90.0;